Literature DB >> 2835391

Comparison of serum and mucosal antibody responses following severe acute rotavirus gastroenteritis in young children.

K Grimwood1, J C Lund, B S Coulson, I L Hudson, R F Bishop, G L Barnes.   

Abstract

The development of mucosal immunity is presumed to be the most important marker of rotavirus infection. The practical difficulties of obtaining small-bowel secretions stimulated this study of the antibody response to acute rotavirus infection at other sites. Forty-four infants admitted to the hospital with rotavirus gastroenteritis had serum, saliva, and feces collected at the acute phase (median, 5.5 days), during convalescence (median, 33.5 days), and 4 months later (median, 12.2 weeks). A subgroup of 19 children also had duodenal juice collected in parallel. Rotavirus-specific immunoglobulin G (IgG), IgA, secretory immunoglobulin, and IgM were measured and compared in all samples. The results showed that the estimation of antirotavirus serum IgM, serum IgG, duodenal juice IgA, and duodenal juice IgM by an enzyme immunoassay indicated an immune response to severe primary rotavirus infection in all children. Four months later, the levels of serum IgG and IgA served as the most sensitive markers of the preceding rotavirus infection. The predictive accuracies of immune responses at different sites in relation to a positive IgA immune response in the duodenum were calculated. Fecal IgA predicted duodenal IgA rotavirus antibodies with accuracies of 86% at 1 month and 92% at 4 months. The high sensitivity of serum IgM and IgG in detecting rotavirus infection and the high predictive accuracy of fecal IgA as an indicator of duodenal IgA abrogates the need for duodenal intubation to detect (or monitor) an immune response to rotavirus infection. This finding has important practical implications for epidemiological studies of acute diarrhea in children and in rotavirus vaccine trials.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2835391      PMCID: PMC266431          DOI: 10.1128/jcm.26.4.732-738.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

Review 1.  Passive immunity in rotaviral infections.

Authors:  D R Snodgrass; P W Wells
Journal:  J Am Vet Med Assoc       Date:  1978-09-01       Impact factor: 1.936

2.  Simple and specific enzyme immunoassay using monoclonal antibodies for serotyping human rotaviruses.

Authors:  B S Coulson; L E Unicomb; G A Pitson; R F Bishop
Journal:  J Clin Microbiol       Date:  1987-03       Impact factor: 5.948

3.  ELISA for rotavirus-specific secretory IgA in human sera.

Authors:  P C Grauballe; K Hjelt; P A Krasilnikoff; P O Schiøtz
Journal:  Lancet       Date:  1981-09-12       Impact factor: 79.321

4.  Serum and intestinal immune response to rotavirus enteritis in children.

Authors:  G P Davidson; R J Hogg; C P Kirubakaran
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

5.  A simple method of duodenal juice collection in association with small bowel biopsy in children.

Authors:  R P Ford
Journal:  Aust Paediatr J       Date:  1981-03

6.  Estimation of rotavirus immunoglobulin G antibodies in human serum samples by enzyme-linked immunosorbent assay: expression of results as units derived from a standard curve.

Authors:  R F Bishop; E Cipriani; J S Lund; G L Barnes; C S Hosking
Journal:  J Clin Microbiol       Date:  1984-04       Impact factor: 5.948

7.  Coproantibody response to rotavirus infection.

Authors:  S Sonza; I H Holmes
Journal:  Med J Aust       Date:  1980-11-01       Impact factor: 7.738

8.  Development of serum and intestinal antibody response to rotavirus after naturally acquired rotavirus infection in man.

Authors:  M Riepenhoff-Talty; S Bogger-Goren; P Li; P J Carmody; H J Barrett; P L Ogra
Journal:  J Med Virol       Date:  1981       Impact factor: 2.327

9.  Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children.

Authors:  R F Bishop; G L Barnes; E Cipriani; J S Lund
Journal:  N Engl J Med       Date:  1983-07-14       Impact factor: 91.245

10.  A prospective study of rotavirus infection in infants and young children.

Authors:  M Gurwith; W Wenman; D Hinde; S Feltham; H Greenberg
Journal:  J Infect Dis       Date:  1981-09       Impact factor: 5.226

View more
  39 in total

1.  Relation of VP7 amino acid sequence to monoclonal antibody neutralization of rotavirus and rotavirus monotype.

Authors:  B S Coulson; C Kirkwood
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

Review 2.  Use of Pathogen-Specific Antibody Biomarkers to Estimate Waterborne Infections in Population-Based Settings.

Authors:  Natalie G Exum; Nora Pisanic; Douglas A Granger; Kellogg J Schwab; Barbara Detrick; Margaret Kosek; Andrey I Egorov; Shannon M Griffin; Christopher D Heaney
Journal:  Curr Environ Health Rep       Date:  2016-09

3.  Measurement of rotavirus-neutralizing coproantibody in children by fluorescent focus reduction assay.

Authors:  B S Coulson; P J Masendycz
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

Review 4.  Rotavirus gene structure and function.

Authors:  M K Estes; J Cohen
Journal:  Microbiol Rev       Date:  1989-12

5.  Production of reassortant viruses containing human rotavirus VP4 and SA11 VP7 for measuring neutralizing antibody following natural infection.

Authors:  R J Gorrell; R F Bishop
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

6.  Comparison of immunoglobulin A (IgA), IgG, and IgM enzyme-linked immunosorbent assays, plaque reduction neutralization assay, and complement fixation in detecting seroresponses to rotavirus vaccine candidates.

Authors:  K Midthun; L Z Pang; J Flores; A Z Kapikian
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

7.  Human milk oligosaccharides shorten rotavirus-induced diarrhea and modulate piglet mucosal immunity and colonic microbiota.

Authors:  Min Li; Marcia H Monaco; Mei Wang; Sarah S Comstock; Theresa B Kuhlenschmidt; George C Fahey; Michael J Miller; Mark S Kuhlenschmidt; Sharon M Donovan
Journal:  ISME J       Date:  2014-02-13       Impact factor: 10.302

8.  Postvaccination Serum Antirotavirus Immunoglobulin A as a Correlate of Protection Against Rotavirus Gastroenteritis Across Settings.

Authors:  Julia M Baker; Jacqueline E Tate; Juan Leon; Michael J Haber; Virginia E Pitzer; Benjamin A Lopman
Journal:  J Infect Dis       Date:  2020-06-29       Impact factor: 5.226

9.  Rotavirus-associated immune thrombocytopenic purpura in children: A retrospective study.

Authors:  Qi Ai; Jing Yin; Sen Chen; Lijin Qiao; Na Luo
Journal:  Exp Ther Med       Date:  2016-08-09       Impact factor: 2.447

10.  Resistance to rotavirus infection in adult volunteers challenged with a virulent G1P1A[8] virus correlated with serum immunoglobulin G antibodies to homotypic viral proteins 7 and 4.

Authors:  Lijuan Yuan; Shinjiro Honma; Inyoung Kim; Albert Z Kapikian; Yasutaka Hoshino
Journal:  J Infect Dis       Date:  2009-11-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.